0.39
+0.014(+3.77%)
Currency In USD
| Previous Close | 0.37 |
| Open | 0.38 |
| Day High | 0.39 |
| Day Low | 0.37 |
| 52-Week High | 1.07 |
| 52-Week Low | 0.26 |
| Volume | 90,966 |
| Average Volume | 4.52M |
| Market Cap | 88.13M |
| PE | -1.67 |
| EPS | -0.23 |
| Moving Average 50 Days | 0.39 |
| Moving Average 200 Days | 0.51 |
| Change | 0.01 |
If you invested $1000 in Vaxart, Inc. (VXRT) 10 years ago, it would be worth $16.28 as of September 09, 2025 at a share price of $0.385. Whereas If you bought $1000 worth of Vaxart, Inc. (VXRT) shares 5 years ago, it would be worth $77.78 as of September 09, 2025 at a share price of $0.385.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vaxart Announces Adjournment of Special Meeting of Stockholders
GlobeNewswire Inc.
Yesterday at 12:00 PM GMT
Meeting adjourned to September 19, 2025 at 8:30 a.m. Pacific Time Adjournment provides stockholders with more time given changes in Board composition, additional governance change considerations and future potential disclosures Vaxart encourages all
Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025
GlobeNewswire Inc.
Sep 03, 2025 12:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- SOUTH SAN FRANCISCO, Calif., September 2, 2025 — Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its pr
Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors
GlobeNewswire Inc.
Sep 02, 2025 8:30 PM GMT
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery pl